Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease ; volume:15 ; number:1 ; day:16 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (16.3.2023), 1-14, 12.2023
- Urheber
-
Pillai, Jagan A.
Bena, James
Bekris, Lynn
Kodur, Nandan
Kasumov, Takhar
Leverenz, James B.
Kashyap, Sangeeta R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01203-y
- URN
-
urn:nbn:de:101:1-2023080609123160546904
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pillai, Jagan A.
- Bena, James
- Bekris, Lynn
- Kodur, Nandan
- Kasumov, Takhar
- Leverenz, James B.
- Kashyap, Sangeeta R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dementia / Alzheimer's Disease
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Predicting Alzheimer’s progression in MCI: a DTI-based white matter network model
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia
Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study
Dementia / Alzheimer's Disease
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Predicting Alzheimer’s progression in MCI: a DTI-based white matter network model
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia
Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study
Dementia / Alzheimer's Disease
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Predicting Alzheimer’s progression in MCI: a DTI-based white matter network model
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia